Case Report: A Case of Bladder Dysfunction due to Myasthenia Gravis

By Kaya Cevdet   Karaman M.  

International Urology and Nephrology, Vol. 37, Iss. 2, 2005-06 ,pp. : 253-255

Springer Publishing Company

Access to resources Recommend Favorite

Tolterodine once-daily in treatment of the overactive bladder

By Peters K.M.   Huang R.R.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 829-829

Elsevier

Access to resources Recommend Favorite

Tolterodine treatment augmented by simplified bladder training in Overactive Bladder (OAB) patients

By Mattiason A.   Massey D.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 133-133

Elsevier

Access to resources Recommend Favorite

Treatment of the non neurogenic overactive bladder with botuline toxin a detrusorinjections

By Marchand W.   Merckx L.   Maes D.   Gillis J.   Everaert K.   De Ridder D.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 220-220

Elsevier

Access to resources Recommend Favorite

Tolterodine once-daily in treatment of the overactive bladder: Reply by the author

By Van Kerrebroeck P.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 831-832

Elsevier

Access to resources Recommend Favorite